Why is Bliss GVS Pharma falling/rising?

As of 27-Jun, Bliss GVS Pharma Ltd is experiencing a rise in its stock price, currently at 157.05, reflecting an increase of 8.05 or 5.4%. The stock has shown strong performance today, outperforming its sector by 4.52% and reaching an intraday high of Rs 159.25, which is a 6.88% increase. Over the past week, the stock has gained 13.60%, and in the last month, it has risen by 20.48%. Despite a year-to-date decline of 4.62%, the stock has generated a significant return of 54.05% over the past year, indicating a strong recovery trend. However, it is important to note that the company has seen a decrease in profits by 19.5% over the same period, which may temper investor enthusiasm. The stock's low debt-to-equity ratio and fair valuation compared to peers suggest stability, contributing positively to its recent price movement.
In the broader market context, Bliss GVS Pharma's short-term performance has significantly outpaced the benchmark, with a 1-week return of 13.60% compared to the Sensex's 2.00% increase. This trend of outperformance is consistent with the stock's historical performance, having beaten the BSE 500 over the last three years, one year, and three months. Despite a recent decline in investor participation, as indicated by a 28.28% drop in delivery volume, the stock remains liquid enough for trading. Overall, the combination of strong recent returns, a solid financial position, and favorable comparisons to the benchmark are driving the stock's upward movement.